Diet, Imaging and Energy Balance Trial (DIET)

Duke University

Status

Completed

Conditions

Obesity

Treatments

Behavioral: Low Fat Diet (LFD)

Behavioral: Low Carbohydrate Ketogenic Diet (LCKD)

Study type

Interventional

Funder types

Other

Identifiers

NCT00787280

Pro00002610

Details and patient eligibility

About

To evaluate whether changes in macronutrient consumption (i.e., switching to a diet low in carbohydrates) can change brain responses to cues depicting foods representing that macronutrient. In addition to answering specific questions regarding the effects of an LCKD, the study will provide general information about relations between brain responses to food cues and a broad arrive of factors including typical diet, food preferences, weight control history and genes.

Full description

We propose a parallel arm randomized clinical trial of two diets-a low carbohydrate ketogenic diet (LCKD) and a low fat diet (LFD). Following screening, eligible participants will undergo a six week dietary intervention that will include 7 clinic visits at the Duke Lifestyle Medicine Clinic (Director: Dr. Westman). In addition to the dietary intervention, participants will undergo fMRI scanning on two occasions: once in the week prior to randomization to a diet (Baseline Scan) and after three weeks of following a diet (Post-Diet Scan). During scanning participants will view food cues in order to assess the effects of diet on brain responses to different macronutrient content categories (e.g., High vs. Low Complex Carbohydrate). In addition to scanning measures, we will also record information regarding dietary intake, food preferences, weight, mood, and diet adherence.

Enrollment

51 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Participants must be 18-50 years old, right handed and have a BMI > 27 kg/m². They must be willing to follow either of the two diets.

Exclusion criteria

weigh over 300lbs.
have uncontrolled hypertension (systolic >160mm Hg, diastolic >100mm Hg)
have hypotension (systolic <90 mm Hg, diastolic <60 mm Hg)
have coronary heart disease, or cardiac rhythm disorder
cerebrovascular disease or peripheral vascular disease that requires intensive hyperlipidemic therapy
other significant co-morbid illnesses such as liver disease (AST or ALT > 100), kidney disease (serum creatinine > 1.5), cancer, severe emphysema, severe hypertriglyceridemia (TG>500)
have diabetes (insulin or diet controlled)
have a current psychiatric disease
have current alcohol abuse (greater than 12 drinks per week)
have current drug abuse (or treatment within the last year)
use of psychiatric medications (including antidepressants, anti-anxiety agents, anti-psychotics, "muscle relaxants" or any other drug that influences mood, cognition, or neurotransmitter systems, i.e. dopamine, norepinephrine, acetylcholine, serotonin, GABA, and glutamate)
have had or have an eating disorder including anorexia nervosa, bulimia nervosa, eating disorder not otherwise specified, binge eating disorder, or any other form of disordered eating
have had any bariatric/weight loss surgery
be taking any diet pills (prescription or over the counter)
have been on any diet in the last 3 months
have any restrictive dietary requirements (including: vegetarians, vegans, or any other dietary restraints)
have any food allergies
be on an exclusively ethnic diet
be females who are pregnant, nursing mothers or likely to become pregnant
have any major medical condition that would make participation unsafe (e.g., have pacemaker or other metallic implant (including dental, orthopedic, or IUD), uncomfortable (e.g., chronic pain), confound results (e.g., psychiatric condition)
be left handed
have glaucoma, color blindness
be using experimental or investigational drugs
or suffering from claustrophobia